Organigram Global Inc.OGI

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.10
Market cap
—
P/E
—
Revenue (FY)
$159.8M
Net income
-$45.4M
Dividend yield
—
1-year total return
-37.1%
Net margin
-28.4%
Revenue growth
—
Debt / equity
0.00x

What Organigram Global Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year20232024
Revenue—$159.8M
Net income—-$45.4M
Free cash flow—-$859,000

More on OGI.

Figures from Organigram Global Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.